SBIR/STTR Research Award

USE OF CHEMICAL ECOLOGY TO PRODUCE ECTEINASCIDINS

Award identifier 01d0aaca8341cc3c7c0b8d5808914eae3db9f3222748f83503166537aa4266a2Awarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1992

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
CALBIOMARINE TECHNOLOGIES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

ENVIRONMENTAL MANIPULATIONS WITHIN CONTROLLED, INTENSIVE AQUACULTURE SYSTEMS WILL BE USED TO ENHANCE THE PRODUCTION OF THE NATURAL PRODUCT ECTEINASCIDINS BY THE MARINE TUNICATE ECTEINASCIDIA TURBINATA. THE PHASE I STUDY WILL EXAMINE THE EFFECTS OF 6 ENVIRONMENTAL FACTORS ON ECTEINASCIDIN PRODUCTION: LIGHT INTENSITY, TEMPERATURE, FEEDING RATE, INORGANIC NITROGEN CONENTRATION, INORGANIC PHOSPHATE CONCENTRATION AND SIMULATED PREDATION TISSUE DAMAGE. REPLICATE COLONIES WILL BE MAINTAINED IN FLOW-THROUGH SEAWATER AQUARIA FOR 8 WEEKS UNDER DIFFERENT TREATMENT REGIMES. TREATMENTS FOUND TO SIGNIFICANTLY AFFECT ECTEINASCIDIN PRODUCTION WILL BE COMBINED IN A FURTHER SERIES OF EXPERIMENTS LASTING 8 WEEKS TO IDENTIFY SYNERGISTIC EFFECTS. THE RESULTS OF THESE INVESTIGATIONS OF THE CHEMICAL ECOLOGY OF THE TUNICATE WILL BE APPLIED TO THE AQUACULTURAL PRODUCTION OF THE ECTEINASCIDINS IN THE PHASE II STUDY. THE ECTEINASCIDINS, WHICH ARE PESENT IN ONLY TRACE AMOUNTS IN THE TUNICATE (.000001 -.0000001), ARE PRESENTLY IN PRECLINICAL DEVELOPMENT AS ANTICANCER AGENTS. DEVELOPMENT OF A RELIABLE SOURCE OF THE DRUG CANDIDATE IS NECESSARY TO MEET THE PROJECTED RESEARCH, CLINICAL AND MARKET DEMANDS. SUCCESSFUL COMPLETION OF THIS PROJECT WILL ENABLE INCREASED AQUACULTURE YIELDS OF THIS HIGH-VALUE PHARMACEUTICAL, POSSIBLY REDUCING PRODUCTION COSTS BY ONE OR MORE ORDERS OF MAGNITUDE. HIGH-YIELD AQUACULTURE PRODUCTION METHODS, BASED ON A KNOWLEDGE OF THE CHEMICAL ECOLOGY OF THE PRODUCING ORGANISMS, CAN ALSO BE APPLIED TO OTHER MARINE INVERTEBRATE DRUGS PRESENTLY THE PHARMACEUTICAL PIPELINE.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.